Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Apache Indian who wrote (444)	2/12/1999 2:20:00 PM
From: Dr. John M. de Castro	Read Replies (1) of 1494

There is no conference call scheduled. There generally isn't for a quarterly report. I don't know anything that you don't. But, let me point out what was NOT said in the release. There was no mention of suspending operations or anything of the kind. All that was said was that "The company will need to secure an infusion of capital to continue the clinical development of its product candidates." I realize that this seems to be reading between the lines. But, it is common for companies that are in serious trouble to let it be known that suspension of operations is a real option. Doing this protects the management from later litigation. The fact that nothing was said in this regard is a clear signal to me that the worse case is that the Memantine trial for Diabetic Neuropathy and the Xerecept trial for peritumoral edema would have to be suspended. I seriously doubt that even that will be necessary. NTII is too close to becoming successful for the board to let it go under for lack of a couple of million. So relax and be patient. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next